I’m Dr. Peter Salgo, a professor of medicine and anesthesiology at Columbia University College of Physicians and Surgeons; and an associate director of Surgical Intensive Care at New York-Presbyterian Hospital. Heart failure is associated with almost one million hospitalizations annually. Preventing readmissions through evidenced-based medicine is a large part of managing this patient population. As a result, much of their care falls to community physicians. On behalf of MD Magazine, I am excited to introduce an upcoming Peer Exchange focusing on congestive heart failure management. The topics will include: disease state information, understanding the current clinical guidelines, and applying them to hospital discharge planning to ensure a smooth transition of care to the community setting. Current therapeutic options, including the clinical rationale for treatment decision making will also be discussed. The esteemed panel will provide the valuable perspectives of the cardiologist as well as the clinical pharmacist in managing this disease. This video series will become available early 2017. We hope you will find it useful and informative.

Coming Soon; Congestive Heart Failure Peer Exchange



I’m Dr. Peter Salgo, a professor of medicine and anesthesiology at Columbia University College of Physicians and Surgeons; and an associate director of Surgical Intensive Care at New York-Presbyterian Hospital. Heart failure is associated with almost one million hospitalizations annually. Preventing readmissions through evidenced-based medicine is a large part of managing this patient population. As a result, much of their care falls to community physicians. On behalf of MD Magazine, I am excited to introduce an upcoming Peer Exchange focusing on congestive heart failure management. The topics will include: disease state information, understanding the current clinical guidelines, and applying them to hospital discharge planning to ensure a smooth transition of care to the community setting. Current therapeutic options, including the clinical rationale for treatment decision making will also be discussed. The esteemed panel will provide the valuable perspectives of the cardiologist as well as the clinical pharmacist in managing this disease. This video series will become available early 2017. We hope you will find it useful and informative.
Episode 1 Coming Soon; Congestive Heart Failure Peer Exchange

Latest Peer Exchange

Type 2 Diabetes: Improving Care in the Community
Type 2 Diabetes: Improving Care in the Community
Differentiating Among Newer Combinations in Diabetes
Differentiating Among Newer Combinations in Diabetes
Switching to an Insulin-Based Combination
Switching to an Insulin-Based Combination
LixiLan Trials in Type 2 Diabetes
LixiLan Trials in Type 2 Diabetes
GLP-1 Receptor Antagonist Therapy in Type 2 Diabetes
GLP-1 Receptor Antagonist Therapy in Type 2 Diabetes
Insulin-Based Combinations in Type 2 Diabetes
Insulin-Based Combinations in Type 2 Diabetes
Early Combination Therapy in Type 2 Diabetes
Early Combination Therapy in Type 2 Diabetes
Preparing Patients for Insulin in Type 2 Diabetes
Preparing Patients for Insulin in Type 2 Diabetes
The Evolving Role of Insulin in Type 2 Diabetes
The Evolving Role of Insulin in Type 2 Diabetes
When Insulin is Needed in Type 2 Diabetes
When Insulin is Needed in Type 2 Diabetes
Factors to Consider in Initial Diabetes Treatment Approach
Factors to Consider in Initial Diabetes Treatment Approach
Overcoming Clinical Inertia in Type 2 Diabetes
Overcoming Clinical Inertia in Type 2 Diabetes
Challenges in Glycemic Control in Type 2 Diabetes
Challenges in Glycemic Control in Type 2 Diabetes
Controlling Diabetes in 2017
Controlling Diabetes in 2017
A Personalized Approach in Type 2 Diabetes
A Personalized Approach in Type 2 Diabetes

Most Popular

@MDMagazine

$vAR$